Inogen [INGN] vs Nevro [NVRO] Detailed Stock Comparison

Inogen Inc.

NASDAQ
Loading...

Nevro Corp.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Inogen Inc. wins in 12 metrics, Nevro Corp. wins in 6 metrics, with 0 ties. Inogen Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Inogen Inc. Nevro Corp. Better
P/E Ratio (TTM) -8.14 144.40 Nevro Corp.
Price-to-Book Ratio 0.99 0.96 Nevro Corp.
Debt-to-Equity Ratio 9.09 108.86 Inogen Inc.
PEG Ratio 0.22 -2.26 Inogen Inc.
EV/EBITDA -9.16 -2.15 Nevro Corp.
Profit Margin (TTM) -6.52% -27.77% Inogen Inc.
Operating Margin (TTM) -12.21% -21.79% Inogen Inc.
Return on Equity -12.43% -43.29% Inogen Inc.
Return on Assets (TTM) -6.35% -9.95% Inogen Inc.
Free Cash Flow (TTM) $-21.60M $-29.23M Inogen Inc.
1-Year Return 0.93% -56.06% Inogen Inc.
Price-to-Sales Ratio (TTM) 0.54 0.55 Inogen Inc.
Enterprise Value $87.44M $180.16M Nevro Corp.
EV/Revenue Ratio 0.25 0.44 Inogen Inc.
Gross Profit Margin (TTM) 43.12% 62.45% Nevro Corp.
Revenue per Share (TTM) $13 $11 Inogen Inc.
Earnings per Share (Diluted) $-0.86 $-3.06 Inogen Inc.
Beta (Stock Volatility) 1.71 0.82 Nevro Corp.
Short % of Float 4.16% N/A N/A

Inogen Inc. vs Nevro Corp. Stock Performance Analysis

Loading Price Chart...

INGN
NVRO

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Inogen Inc.-1.97%-7.45%-12.63%-1.46%-9.64%-8.14%
Nevro Corp.0.00%N/AN/AN/AN/AN/A

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Inogen Inc.0.93%-40.02%-89.81%-86.81%-57.16%-57.16%
Nevro Corp.-56.06%-92.38%-94.65%-89.12%-76.92%-76.92%

Performance & Financial Health Analysis: Inogen Inc. vs Nevro Corp.

MetricINGNNVRO
Market Information
Market Cap i$190.35M$224.09M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i313,1051,058,636
90 Day Avg. Volume i253,0821,147,389
Last Close$5.97$5.84
52 Week Range$5.34 - $9.13$3.16 - $13.84
% from 52W High-34.61%-57.80%
All-Time High$287.79 (Sep 10, 2018)$188.14 (Dec 21, 2020)
% from All-Time High-97.93%-96.90%
Growth Metrics
Quarterly Revenue Growth0.02%-0.09%
Quarterly Earnings Growth0.02%-0.09%
Financial Health
Profit Margin (TTM) i-0.07%-0.28%
Operating Margin (TTM) i-0.12%-0.22%
Return on Equity (TTM) i-0.12%-0.43%
Debt to Equity (MRQ) i9.09108.86
Cash & Liquidity
Book Value per Share (MRQ)$7.06$6.11
Cash per Share (MRQ)$4.39$7.72
Operating Cash Flow (TTM) i$-11,216,000$-19,439,000
Levered Free Cash Flow (TTM) i$-21,157,376$-4,766,875
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Inogen Inc. vs Nevro Corp.

MetricINGN (Apr 24, 2026)NVRO (May 17, 2025)
Price Ratios
P/E Ratio (TTM) i-8.14144.40
Forward P/E i-22.45-2.26
PEG Ratio i0.22-2.26
Price to Sales (TTM) i0.540.55
Price to Book (MRQ) i0.990.96
Market Capitalization
Market Capitalization i$190.35M$224.09M
Enterprise Value i$87.44M$180.16M
Enterprise Value Metrics
Enterprise to Revenue i0.250.44
Enterprise to EBITDA i-9.16-2.15
Risk & Other Metrics
Beta i1.710.82
Book Value per Share (MRQ) i$7.06$6.11

Financial Statements Comparison: Inogen Inc. vs Nevro Corp.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricINGN (2025)NVRO (2024)
Revenue/Sales i348.67M408.52M
Cost of Goods Sold i194.40M138.99M
COGS % of Revenue i55.8%34.0%
Gross Profit i154.27M269.53M
Gross Margin i44.2%66.0%
Research & Development i19.40M51.51M
Operating Income (EBIT) i-30.21M-94.70M
Operating Margin i-8.7%-23.2%
EBITDA i-9.55M-67.70M
EBITDA Margin i-2.7%-16.6%
Pre-Tax Income i-23.38M-112.35M
Pre-Tax Income % of Revenue i-6.7%-27.5%
Income Tax i-632,0001.09M
Income Tax % of Revenue i-0.2%0.3%
Net Income (Profit) i-22.75M-113.44M
Profit Margin i-6.5%-27.8%

Balance Sheet & Liquidity Metrics

MetricINGN (2025)NVRO (2024)
Cash & Equivalents i103.73M94.54M
Total Current Assets i198.30M476.00M
Total Current Assets % of Revenue i56.9%116.5%
Total Current Liabilities i63.54M102.94M
Total Current Liabilities % of Revenue i18.2%25.2%
Long-Term Debt i14.31M213.19M
Long-Term Debt % of Revenue i4.1%52.2%
Total Shareholders Equity i192.23M231.01M
Retained Earnings i-175.58M-812.85M
Retained Earnings % of Revenue i-50.4%-199.0%
Property, Plant & Equipment i101.83M36.77M

Cash Flow Statement Comparison

MetricINGN (2025)NVRO (2024)
Operating Cash Flow i-16.25M-25.99M
Operating Cash Flow % of Revenue i-4.7%-6.4%
Capital Expenditures i-10.38M-9.79M
Free Cash Flow i-21.60M-29.23M
FCF Margin i-6.2%-7.2%
Debt Repayment iN/A0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricINGNNVRO
Shares Short i1.12MN/A
Short Ratio i4.29N/A
Short % of Float i4.16%N/A
Shares Outstanding i27.23M37.82M
Float Shares i24.03M34.23M
% Held by Insiders i11.97%2.84%
% Held by Institutions i76.68%110.59%
% Held by Public i11.35%-13.43%

Dividend Analysis & Yield Comparison: Inogen Inc. vs Nevro Corp.

MetricINGNNVRO
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A